Skip to main content

Our News

PressNED Mourns the Passing of Dr. Brian Leyland-Jones (1949-2026)
January 12, 2026

NED Mourns the Passing of Dr. Brian Leyland-Jones (1949-2026)

NED mourns the passing of Brian Leyland-Jones, BSc (1st Class Honors), MB BS, PhD, FACP, FRCPC, NED’s Scientific Advisory Board Chair, who passed away on Thursday, January 8, 2026 at…
NED Bio Admin
Love0
NewsNED Biosystems Appoints Yanchun “Lily” Li to the Board of Directors
November 3, 2025

NED Biosystems Appoints Yanchun “Lily” Li to the Board of Directors

NED Biosystems is thrilled to announce the appointment to its Board of Directors of distinguished entrepreneur, investor, and global philanthropist, Yanchun “Lily” Li. Ms. Li brings an international strategic focus…
NED Bio Admin
Love0
NewsNED Biosystems Appoints José Trevejo, MD, PhD to the Board of Directors
November 20, 2024

NED Biosystems Appoints José Trevejo, MD, PhD to the Board of Directors

NED Biosystems strengthened its Board of Directors with the appointment of a highly accomplished physician-scientist and biotechnology executive, José Trevejo, MD, PhD. The appointment of Dr. Trevejo, who has led…
NED Bio Admin
Love0
NewsNED Biosystems Appoints John Thomas, CPA to the Board of Directors
September 25, 2024

NED Biosystems Appoints John Thomas, CPA to the Board of Directors

NED Biosystems has added key finance expertise to its Board of Directors through the recent appointment of John Thomas, CPA. Mr. Thomas brings to the board almost 40 years of…
NED Bio Admin
Love0
NewsPressInstitute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset
November 8, 2023

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

From Inside Precision Medicine   The Institute for Systems Biology (ISB) and NED Biosystems (NED) will collaborate on an intriguing clinical trial that aims to use a cocktail of several…
NED Bio Admin
Love0
NewsPressInstitute for Systems Biology and NED Biosystems announce collaboration to show how cancer’s onset may be reversed
October 30, 2023

Institute for Systems Biology and NED Biosystems announce collaboration to show how cancer’s onset may be reversed

NED’s cancer treatment, NED-170, takes a systems approach that combines repurposed, oral agents that are well documented in humans to affect critical cancer disease-driver processes at doses that lack customary…
NED Bio Admin
Love0
NewsNED Biosystems Congratulates Board Director Carolina Alarco on Receiving Impact on Life Sciences Diversity, Equity, & Inclusion Award
October 6, 2022

NED Biosystems Congratulates Board Director Carolina Alarco on Receiving Impact on Life Sciences Diversity, Equity, & Inclusion Award

NED congratulates our Board Director Carolina Alarco on receiving LabCentral Ignite's inaugural Ted W. Love Award for Individual Impact on Life Sciences Diversity, Equity, & Inclusion at the first annual…
NED Bio Admin
Love0
NewsNED Biosystems Appoints Two New Board Members: Carolina Alarco and Louise Forlenza, CPA
February 18, 2022

NED Biosystems Appoints Two New Board Members: Carolina Alarco and Louise Forlenza, CPA

NED Biosystems welcomes two highly accomplished business development professionals Carolina Alarco and Louise Forlenza, CPA to its Board of Directors. Ms. Alarco and Ms. Forlenza bring over 60 years of…
NED Bio Admin
Love0
NewsNED Biosystems’ Board Director and Scientific Advisor Geoffrey Ling, MD, PhD, Col (Ret) Testifies on ARPA-H Proposal Before Congress
February 8, 2022

NED Biosystems’ Board Director and Scientific Advisor Geoffrey Ling, MD, PhD, Col (Ret) Testifies on ARPA-H Proposal Before Congress

https://vimeo.com/676399681 Energy and Commerce Subcommittee Holds Hearing on Advanced Research Projects Agency for Health (ARPA-H) Proposal
NED Bio Admin
Love0
PressNED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor
October 6, 2020

NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor

CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) — NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour,…
NED Bio Admin
Love0
NewsLeading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
September 2, 2020

Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board

CAMBRIDGE, Mass., Sept. 2, 2020 (SEND2PRESS NEWSWIRE) — NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy,…
NED Bio Admin
Love0
NewsNED Biosystems Unveils First Peer-Reviewed Presentation at ASCO Breakthrough Summit
November 14, 2019

NED Biosystems Unveils First Peer-Reviewed Presentation at ASCO Breakthrough Summit

Promising outcomes for advanced cancers associated with novel investigational cancer therapeutic   Cambridge, Mass., October 13, 2019 – NED Biosystems, Inc., a clinical-stage biotech company investigating solutions for a broad range of…
NED Bio Admin
Love1
Close Menu